DURYSTA is a Intracameral Implant in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Bimatoprost.
Product ID | 0023-9652_139d1960-717c-4728-b28e-b3fbd2050c8b |
NDC | 0023-9652 |
Product Type | Human Prescription Drug |
Proprietary Name | DURYSTA |
Generic Name | Bimatoprost |
Dosage Form | Implant |
Route of Administration | INTRACAMERAL |
Marketing Start Date | 2020-03-04 |
Marketing Category | NDA / NDA |
Application Number | NDA211911 |
Labeler Name | Allergan, Inc. |
Substance Name | BIMATOPROST |
Active Ingredient Strength | 10 ug/1 |
Pharm Classes | Prostaglandin Analog [EPC],Prostaglandins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-03-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA211911 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2020-03-04 |
Ingredient | Strength |
---|---|
BIMATOPROST | 10 ug/1 |
NDC | Brand Name | Generic Name |
---|---|---|
0023-9652 | DURYSTA | bimatoprost |
0781-6206 | Bimatoprost | Bimatoprost |
42571-128 | BIMATOPROST | BIMATOPROST |
50383-908 | Bimatoprost | Bimatoprost |
50383-912 | Bimatoprost | Bimatoprost |
57297-429 | bimatoprost | bimatoprost |
60505-0583 | Bimatoprost | Bimatoprost |
62332-507 | Bimatoprost | Bimatoprost |
62332-511 | bimatoprost | bimatoprost |
65862-802 | Bimatoprost | Bimatoprost |
68083-295 | Bimatoprost | Bimatoprost |
68083-296 | Bimatoprost | Bimatoprost |
68083-439 | Bimatoprost | Bimatoprost |
0023-3616 | LATISSE | bimatoprost |
0023-3205 | LUMIGAN | bimatoprost |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DURYSTA 88484542 not registered Live/Pending |
Allergan, Inc. 2019-06-22 |
DURYSTA 88345288 not registered Live/Pending |
Allergan, Inc. 2019-03-18 |
DURYSTA 87409340 not registered Dead/Abandoned |
Allergan, Inc. 2017-04-12 |
DURYSTA 86809824 not registered Dead/Abandoned |
Allergan, Inc. 2015-11-04 |